Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Persistent vancomycin and high-level gentamicin-resistant Enterococcus faecium bacteremia and intra-aortic thrombus in an extremely low birth-weight infant

Abstract

Vancomycin-resistant Enterococcus (VRE) sepsis is emerging as a significant problem in the intensive care setting. The treatment at any age is challenging, but there is a dearth of information on this infection and its treatment in the very premature infant. We describe successful treatment of persistent bacteremia caused by Enterococcus faecium with vancomycin and high-level gentamicin resistance in a 10-day-old former 23-week premature male infant.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. European Antimicrobial Resistance Surveillance System Annual Report 2005, www.hpsc.ie.

  2. Ang JY, Lua JL, Turner DR, Asmar BI . Vancomycin-resistant enterococcus faecium endocarditis in a premature infant successfully treated with linezolid. Pediatr Infect Dis J 2003; 12: 1102–1103.

    Google Scholar 

  3. Hoehn R, Groll AH, Schaefer V, Bauer K, Schloesser RL . Linezolid treatment of glycopeptide-resistant Enterococcus faecium in very low birth weight premature neonates. Intern Journ of Antimicrob Agents 2006; 27: 256–258.

    Article  CAS  Google Scholar 

  4. Kaplan SL . Safety and tolerability of linezolid in children. Pediatr Infect Dis J 2003; 22: S193–S200.

    Article  Google Scholar 

  5. Graham PL, Ampofo K, Saiman L . Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis. Pediatr Infect Dis J 2002; 21: 798–800.

    Article  Google Scholar 

  6. Kearns GL, Jungbluth GL, Abdel-Rahman SM, Hopkins NK, Welshman IR, Grzebyk RP et al. Impact of ontogeny on linezolid disposition in neonates and infants. Clin Pharmacol Ther 2003; 74: 413–422.

    Article  CAS  Google Scholar 

  7. Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S et al. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates. Pediatr Infect Dis J 2003; 22 (9 Suppl): S158–S163.

    Article  Google Scholar 

  8. Klingkowski U, Huth RG, Habermehl P, Knuf M . Linezolid in two premature babies with necrotizing enterocolitis and infection with vancomycin-resistant enterococcus. Klin Padiatr 2004; 216: 21–23.

    Article  CAS  Google Scholar 

  9. Metha DK . British National Formulary (BNF) 55. September 2007, p 104.

  10. Fanos V, Cuzzolin L, Atzei A, Testa M . Antibiotics and antifungals in neonatal intensive care units: a review. J Chemother 2007; 19: 5–20.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N Hapnes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hapnes, N., Twomey, A. & Knowles, S. Persistent vancomycin and high-level gentamicin-resistant Enterococcus faecium bacteremia and intra-aortic thrombus in an extremely low birth-weight infant. J Perinatol 29, 66–68 (2009). https://doi.org/10.1038/jp.2008.137

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2008.137

Search

Quick links